Dr Lee Soo Chin
Associate Director (Research) and Senior Consultant, Department of Haematology-Oncology, National University Cancer Institute, Singapore (NCIS)
Adjunct Research Associate Professor, Cancer Science Institute of Singapore, National University Singapore
Dr Lee obtained her medical degrees from the National University of Singapore and the Royal College of Physicians, United Kingdom, and completed a fellowship in cancer genetics at Johns Hopkins School of Medicine, United States. She is currently a Senior Consultant in Medical Oncology and Associate Director of Research at the National University Cancer Institute, Singapore, and Senior Principal Investigator at the Cancer Science Institute, Singapore. She is ex-Chairperson of the Chapter of Medical Oncologists, Academy of Medicine, Singapore, and has been a member of the Ministry of Health Specialist Accreditation Board for Medical Oncology since 2009. She has been Chair of the National Healthcare Group Domain-Specific Ethics Review Board B since 2008. She is also a member of the Singapore Ministry of Health Drug Advisory Committee for Oncology drugs.
She specializes in breast cancer and directs the Cancer Genetics program at the National University Cancer Institute, Singapore. Her research focus is on breast cancer, pharmacogenetics and cancer genetics, and she has been the Principal Investigator of more than 30 industry-sponsored and investigator-initiated breast cancer clinical trials. She directs the Haematology-Oncology Research Group, a cancer clinical trials unit that conducts 80-100 phase I-III therapeutics clinical trials in solid tumors and haematological malignancies at the National University Cancer Institute.
She was awarded the Singapore National Medical Research Council Senior Clinician Scientist Award in 2009 and again in 2015, and has almost 120 peer-reviewed publications in major oncology and pharmacogenetics journals, including Cancer, Oncology, Journal of Clinical Oncology, Annals of Oncology, British Journal of Cancer, Clinical Pharmacology and Therapeutics, Pharmacogenetics and Genomics, Breast Cancer Research and Treatment, New England Journal of Medicine and Nature Genetics. She has reviewed for international journals including Gut, British Journal of Cancer, Pharmacogenetics and Genomics, Personalized Medicine, Annals of Oncology, Cancer Chemotherapy and Pharmacology, and Pharmacogenomics.
Education and Fellowships
MBBS, MRCP (UK), M Med (Int Med), FAMS, FRCP (UK), Familial Cancer Risk Assessment and Management Credential (Institute for Clinical Evaluation, USA)
• Breast cancer
• Cancer genetics
Awards and Honours
• HMDP Fellowship (FY2000) for cancer genetics fellowship with the John Hopkins University, USA, March 1999 to August 2000
• NUH STAR award for excellent clinical service (individual), 2005
• National Medical Research Clinical Junior Clnician Scientist Investigator Award, 2006
• National Healthcare Group Dr Ang Ah Ling Research Ethics Training Award, 2009
• A*STAR Clinician Scientist Award (Senior Investigator), 2009 and 2015
• Member, American Society of Clinical Oncology
• Fellow and Past Chairperson, Chapter of Medical Oncologists, Academy of Medicine, Singapore Member, Singapore Society of Oncology